The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpire Healthcare Regulatory News (SPI)

Share Price Information for Spire Healthcare (SPI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 258.00
Bid: 257.50
Ask: 259.00
Change: 1.00 (0.39%)
Spread: 1.50 (0.583%)
Open: 250.00
High: 259.50
Low: 250.00
Prev. Close: 257.00
SPI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - SPIRE HEALTHCARE GROUP PLC

9 Jul 2021 07:53

 

 
FORM 8.3
 
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the “Code”)
 
 

1

KEY INFORMATION
 
(a) Full name of discloser:MELQART ASSET MANAGEMENT (UK) LTD
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

N/A

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Spire Healthcare Group plc

Use a separate form for each offeror/offeree
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

08 July 2021

For an opening position disclosure, state the latest practicable date prior to the disclosure
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?NO
If it is a cash offer or possible cash offer, state “N/A”If YES, specify which:
 

2

POSITIONS OF THE PERSON MAKING THE DISCLOSURE
 
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
 
(a)Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)
 
Class of relevant security:1p ordinary
 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

 

 

 

 

(2) Cash-settled derivatives:

11,673,100

2.91%

 

 

 
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

TOTAL:

11,673,100

2.91%

 

 

 
 
All interests and all short positions should be disclosed.
 
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
 
(b)Rights to subscribe for new securities (including directors’ and other employee options)
 
Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:
 
 

3

DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
 
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
 
The currency of all prices and other monetary amounts should be stated.
 
(a)Purchases and sales
 
Class of relevant securityPurchase/saleNumber of securitiesPrice per unit (GBp)
 
 
 
 
(b)Cash-settled derivative transactions
 
Class of relevant securityProduct descriptionNature of dealingNumber of reference securitiesPrice per unit (GBp)
e.g. CFDe.g. opening/closing a long/short position, increasing/reducing a long/short position

1p ordinary

CFD

increasing a long position

300,000

224.00

1p ordinary

CFD

increasing a long position

150,000

221.50

1p ordinary

CFD

increasing a long position

150,000

220.00

1p ordinary

CFD

increasing a long position

730,000

221.59

1p ordinary

CFD

increasing a long position

150,000

220.51

 
(c)Stock-settled derivative transactions (including options)
 
(i)Writing, selling, purchasing or varying
 
Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitTypeExpiry dateOption money paid/ received per unit
e.g. American, European etc.
 
 
(ii)Exercise
 
Class of relevant securityProduct descriptionExercising/ exercised againstNumber of securitiesExercise price per unit
e.g. call option
 
 
 
(d)Other dealings (including subscribing for new securities)
 
Class of relevant securityNature of dealingDetailsPrice per unit (if applicable)
e.g. subscription, conversion
 
 
 
 

4

OTHER INFORMATION
 
(a)Indemnity and other dealing arrangements
 
Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None
 
 
 
(b)Agreements, arrangements or understandings relating to options or derivatives
 
Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state “none”
None
 
 
 
(c)Attachments
 
Is a Supplemental Form 8 (Open Positions) attached?NO
 
 
Date of disclosure:09 July 2021
Contact name:Deepak Verma
Telephone number:+44 (0)20 3826 4493
 
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
 
The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.
 
The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20210708006016/en/

Copyright Business Wire 2021

Date   Source Headline
27th Jan 20207:00 amRNSRe: Media coverage
16th Jan 20207:00 amRNSTrading Statement
14th Jan 20201:01 pmRNSHolding(s) in Company
13th Jan 20203:37 pmRNSHolding(s) in Company
13th Jan 20203:34 pmRNSHolding(s) in Company
5th Dec 201911:28 amRNSDirector Declaration
1st Nov 20197:00 amRNSCompletion of disposal
22nd Oct 20194:13 pmRNSHolding(s) in Company
22nd Oct 20194:12 pmRNSHolding(s) in Company
23rd Sep 201912:15 pmRNSHolding(s) in Company
16th Sep 20197:00 amRNSHalf-year Report
13th Sep 20199:45 amRNSHolding(s) in Company
13th Sep 20199:45 amRNSHolding(s) in Company
9th Aug 20191:00 pmRNSDirector/PDMR Shareholding
5th Aug 20197:00 amRNSSpire agrees renewed contract with Bupa UK
11th Jul 20197:00 amRNSRenewed contract with AXA PPP Healthcare
24th Jun 201911:10 amRNSHolding(s) in Company
10th Jun 201910:10 amRNSHolding(s) in Company
31st May 20199:00 amRNSMilton Keynes hospital contract termination
16th May 20192:04 pmRNSResult of AGM
16th May 20198:58 amRNSDirectorate Change
16th May 20197:00 amRNSTrading update
3rd May 201912:13 pmRNSDirector/PDMR Shareholding
17th Apr 20193:22 pmRNSHolding(s) in Company
10th Apr 201912:04 pmRNSNotice of AGM
26th Mar 201912:49 pmRNSDirector/PDMR Shareholding
25th Mar 20192:47 pmRNSHolding(s) in Company
21st Mar 20192:46 pmRNSHolding(s) in Company
14th Mar 20198:25 amRNSDirectorate Change
8th Mar 20193:32 pmRNSHolding(s) in Company
28th Feb 20197:00 amRNSBoard Change
28th Feb 20197:00 amRNSFinal Results
30th Jan 20191:40 pmRNSHolding(s) in Company
15th Jan 20197:00 amRNSPost-close trading update
7th Dec 20189:22 amRNSHolding(s) in Company
26th Nov 20181:38 pmRNSHolding(s) in Company
16th Nov 201811:45 amRNSCQC upgrades Spire Hull & East Riding rating
5th Nov 20182:35 pmRNSDirector/PDMR Shareholding
8th Oct 20183:54 pmRNSDirector/PDMR Shareholding
1st Oct 20183:29 pmRNSDirector/PDMR Shareholding
1st Oct 201811:02 amRNSSale of site of former Spire Manchester Hospital
21st Sep 20181:21 pmRNSDirector/PDMR Shareholding
18th Sep 20189:50 amRNSInterim Results - Replacement
18th Sep 20187:00 amRNSInterim results
18th Sep 20187:00 amRNSAppointment of new Chief Operating Officer
17th Sep 20183:12 pmRNSHolding(s) in Company
12th Sep 20182:49 pmRNSHolding(s) in Company
10th Aug 20182:47 pmRNSHolding(s) in Company
9th Aug 20183:36 pmRNSDirector/PDMR Shareholding
6th Aug 20187:00 amRNSTrading Update and Revised Outlook

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.